Not recruiting yet
To Evaluate the Effectiveness and Safety of Single-port Robotic-assisted Subcutaneous Gland Resection in Males
NCT07353411 · The First Affiliated Hospital with Nanjing Medical University · Updated 20 Jan 2026
- What is being tested
- Single-port Robotic-assisted Subcutaneous Gland Resection in males
- For
- Gynecomastia
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 17 years to 75 years. About 20 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started 1 Jan 2026, ends 30 Nov 2028. Registered 20 Jan 2026.
- Results
- None posted yet.
In the researchers' words
The new technology of robotic surgery system, as an emerging technology, has shown certain application prospects in breast surgery. However, the new technology of robotic surgery system in China in the treatment of gynecomastia is still in the exploratory stage and needs to be further improved. This prospective, single-center, single-arm clinical study was conducted to use the single-port robot and evaluate the effectiveness and safety of the subcutaneous gland resection in the treatment of gynecomastia.